FDA: Pfizer COVID vaccine looks effective for young kids

An FDA panel has completed the first independent review of Pfizer's COVID vaccine for children aged 5 to 11 and in almost every scenario the benefit for preventing hospitalizations and death outweigh any serious potential side effects.